Document:

EX-4.1

 Exhibit 4.1 

CANTEL MEDICAL LLC 
 AND 

STERIS PLC 
 AND 

WELLS FARGO BANK, NATIONAL ASSOCIATION, 

as Trustee 
 FIRST SUPPLEMENTAL
INDENTURE 
 June 2, 2021 

3.25% Convertible Senior Notes due 2025 

FIRST SUPPLEMENTAL INDENTURE, dated as of June 2, 2021 (this “First Supplemental Indenture”), among CANTEL
MEDICAL LLC, a Delaware limited liability company (formerly known as Cantel Medical Corp., the “Company”), STERIS PLC, a company incorporated under the laws of Ireland (“Parent”), and WELLS FARGO BANK, NATIONAL
ASSOCIATION, as trustee under the Original Indenture referred to below (the “Trustee”). 
 W I T N E S S E T H: 

WHEREAS, the Company and the Trustee are parties to an Indenture, dated as of May 15, 2020 (the “Original
Indenture”), pursuant to which the Company issued its 3.25% Convertible Senior Notes due 2025 (the “Notes”); 

WHEREAS, the Company entered into an Agreement and Plan of Merger, dated as of January 12, 2021, as amended by Amendment to Agreement and
Plan of Merger, dated as of March 1, 2021 (the “Merger Agreement”), by and among the Company, Parent, Solar New US Holding Corporation (formerly known as Solar New US Holding Co, LLC), a Delaware corporation and indirect and
wholly-owned subsidiary of Parent (“US HoldCo”) and Crystal Merger Sub 1, LLC, a Delaware limited liability company and direct and wholly-owned subsidiary of US HoldCo (“Crystal Merger Sub”); 

WHEREAS, pursuant to the terms of the Merger Agreement, prior to the closing of the transactions contemplated by the Merger Agreement (the
“Closing”), the Company incorporated Canyon HoldCo, Inc., a Delaware corporation and direct and wholly owned subsidiary of the Company (“Canyon Newco”), and Grand Canyon Merger Sub, Inc., a Delaware corporation and
direct and wholly owned subsidiary of Canyon Newco (“Canyon Merger Sub”), and on March 1, 2021, Canyon Newco, Canyon Merger Sub and the Company entered into a joinder to the Merger Agreement through which Canyon Newco and
Canyon Merger Sub became parties to the Merger Agreement. The Merger Agreement provided for, among other things, (a) the merger of Canyon Merger Sub with and into the Company with the Company surviving the merger as a

 
direct and wholly-owned subsidiary of Canyon Newco (the “Pre-Closing Merger”), (b) immediately following the Pre-Closing Merger, the conversion of the Company from a Delaware corporation to a Delaware limited liability company (the “Pre-Closing Conversion”),
(c) immediately following the Pre-Closing Conversion, the merger of Crystal Merger Sub with and into Canyon Newco with Canyon Newco surviving the merger as a direct and wholly-owned subsidiary of US
Holdco (the “First Merger”) and (d) immediately after the First Merger, the merger of Canyon Newco with and into US Holdco, with US Holdco surviving the merger and remaining an indirect and wholly-owned subsidiary of Parent
(the “Second Merger” and, together with the Pre-Closing Merger and the First Merger, the “Mergers”); 

WHEREAS, pursuant to the Merger Agreement and subject to the terms and conditions therein, at the effective time of the Pre-Closing Merger (the “Pre-Closing Merger Effective Time”), each share of common stock, par value $0.10 per share, of the Company (the “Company
Common Stock”) issued and outstanding immediately prior to the Pre-Closing Merger Effective Time will be automatically converted into the right to receive one share of common stock of Canyon Newco
(the “Canyon Newco Common Stock”); 
 WHEREAS, pursuant to the Merger Agreement and subject to the terms and conditions
therein, (x) at the effective time of the First Merger (the “First Merger Effective Time”), each share of Canyon Newco Common Stock (previously Company Common Stock) issued and outstanding immediately prior to the First Merger
Effective Time will be automatically converted into the right to receive a combination of (i) ordinary shares, par value $0.001 per share, of Parent (“Parent Shares”) and (ii) cash (as described herein), the separate
existence of Crystal Merger Sub will cease, and Canyon Newco will survive the First Merger as an direct and wholly-owned subsidiary of US Holdco, and (y) immediately thereafter, at the effective time of the Second Merger, the separate corporate
existence of Canyon Newco will cease, and US Holdco will survive the Second Merger as an indirect and wholly-owned subsidiary of Parent; 

WHEREAS, Section 10.01 of the Original Indenture provides that the Company, when authorized by the resolutions of the Board of Directors
of the Company, and the Trustee, at the Company’s expense, may from time to time and at any time enter into a supplemental indenture, to provide, among other things, in connection with any Merger Event that the Notes are convertible into
Reference Property (as defined below), subject to the provisions of Section 14.02 of the Original Indenture, and make such related changes to the terms of the Notes to the extent expressly required by Section 14.07 of the Original
Indenture; 
 WHEREAS, Section 14.07 of the Original Indenture provides that in the case of a consolidation, merger or combination
involving the Company, as a result of which Company Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (a “Merger Event”), the Holder of each Note shall have the right to
convert each $1,000 principal amount of Notes into a right to convert such principal amount of Notes into the kind and amount of shares of stock, other securities or other property or assets that a holder of a number of shares of Company Common
Stock equal to the Conversion Rate immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property,” with each “unit of Reference Property” meaning the kind and amount of
Reference Property that a holder of one share of Company Common Stock is entitled to receive); 

  
 2 

 WHEREAS, upon such Merger Event and, prior to or at the effective time of such Merger Event,
the Company or the successor or purchasing Person, as the case may be, shall execute with the Trustee a supplemental indenture permitted under Section 10.01(h) of the Original Indenture providing for such right to convert each $1,000 principal
amount of Notes into the Reference Property; provided, however, that the Company shall have the continued right, subject to Section 14.02 of the Original Indenture, to determine the Settlement Method with respect to any conversion of Notes;

 WHEREAS, in connection with the execution and delivery of this First Supplemental Indenture, the Trustee has received an Officer’s
Certificate as contemplated by Sections 10.05 and 14.07(b) of the Original Indenture and Opinion of Counsel as contemplated by Section 10.05 of the Original Indenture; and 

WHEREAS, the Company and Parent have requested and hereby request that the Trustee execute and deliver this First Supplemental Indenture and
have satisfied all requirements necessary to make this First Supplemental Indenture a valid and binding instrument, enforceable against each of the Company and the Parent in accordance with its terms. 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged,
the Company, Parent and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders as follows: 
 ARTICLE I

 DEFINITIONS 

Section 1.01    Definitions in this First Supplemental Indenture. A term defined in the Original Indenture has
the same meaning when used in this First Supplemental Indenture unless such term is otherwise defined herein or amended or supplemented pursuant to this First Supplemental Indenture. The words “herein,” “hereof,”
“hereunder,” and words of similar import refer to this First Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision. 

ARTICLE II 
 EFFECT OF MERGER ON
CONVERSION RIGHT 
 Section 2.01    Parent to Provide Parent Shares. Parent hereby irrevocably and
unconditionally agrees to be bound by the terms of this First Supplemented Indenture applicable to it and to issue Parent Shares as necessary to satisfy the Company’s obligations with respect to any Notes validly surrendered for conversion
pursuant to Article 14 of the Original Indenture. 
 Section 2.02    Conversion Right. (a) The
Company and Parent expressly agree that, in accordance with Section 14.07 of the Original Indenture, immediately after the Pre-Closing Merger Effective Time and before the First Merger Effective Time, the
Holder of each Note that was outstanding as of the Pre-Closing Merger Effective Time shall have the right to convert each $1,000 principal amount of such Note into a number of units of Reference Property equal
to the Conversion Rate (as defined in the Original Indenture). The Conversion Rate immediately following the Pre-Closing Merger Effective Time will be 24.0912 Units of Reference Property for each $1,000
principal amount of Notes. As used in this Section 2.02(a), “Unit of Reference Property” shall mean one share of Canyon NewCo Common Stock. 

  
 3 

 (b)    The Company and Parent expressly agree that, in accordance with
Section 14.07 of the Original Indenture, at and after the First Merger Effective Time, the Holder of each Note that was outstanding as of the First Merger Effective Time shall have the right to convert each $1,000 principal amount of such Note
into a number of units of Reference Property equal to the Conversion Rate (as defined in the Original Indenture). The Conversion Rate immediately following the First Merger Effective Time will be 24.0912 Units of Reference Property for each
$1,000 principal amount of Notes (prior to giving effect to any Additional Shares added to the Conversion Rate in accordance with Section 14.03). As used in this Section 2.02(b), “Unit of Reference Property” shall mean,
collectively, (i) $16.93 in cash and (ii) 0.33787 Parent Shares. 
 (c)    The provisions of the Original
Indenture, as modified herein, including without limitation, (i) all references and provisions respecting the terms “Common Stock,” “Conversion Price,” “Conversion Rate,” “Daily Conversion Value,”
“Daily VWAP,” “Ex-Dividend Date,” “Last Reported Sale Price,” “Observation Period,” “Settlement Amount,” “Cash Settlement,” “Market Disruption
Event,” and “Trading Day” shall continue to apply, mutatis mutandis, to the Holders’ right to convert their Notes into applicable Units of Reference Property. The Conversion Rate shall be adjusted as a result of events
occurring subsequent to the date hereof with respect to the Reference Property as nearly equivalent as may be practicable to the adjustments of the Conversion Rate provided for in Article 14 of the Original Indenture. 

ARTICLE III 
 MISCELLANEOUS 

Section 3.01    Ratification of Original Indenture. The Original Indenture, as supplemented by this First
Supplemental Indenture, is in all respects ratified and confirmed, and this First Supplemental Indenture shall be deemed part of the Original Indenture in the manner and to the extent herein and therein provided. 

Section 3.02    Conflict with Original Indenture. To the extent not expressly amended or modified by this
First Supplemental Indenture, the Original Indenture shall remain in full force and effect. If any provision of this First Supplemental Indenture is inconsistent with any provision of the Original Indenture, the provision of this First Supplemental
Indenture shall control. 
 Section 3.03    Successors. All agreements of the Company, the Parent and the
Trustee in this First Supplemental Indenture shall bind their respective successors. 

Section 3.04    Governing Law. THIS FIRST SUPPLEMENTAL INDENTURE AND THE NOTES SHALL BE GOVERNED BY,
AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF
OR RELATING TO THIS FIRST SUPPLEMENTAL INDENTURE, THE ORIGINAL INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY AND THEREBY. 

  
 4 

 Section 3.05    Counterparts. This First Supplemental
Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. The exchange of copies of this First Supplemental Indenture and of
signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this First Supplemental Indenture as to the parties hereto and may be used in lieu of the original First Supplemental Indenture for all purposes.
Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 
 The
words “execution,” “signed,” “signature,” and words of like import in this First Supplemental Indenture shall be deemed to include electronic signatures or electronic records, each of which shall be of the same legal
effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global
and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. 

Section 3.06    Headings. The headings of the Articles and Sections of this First Supplemental Indenture have
been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 

Section 3.07    Severability. In case any provision in this First Supplemental Indenture shall be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or
unenforceability. 
 Section 3.08    Trustee Not Responsible for Recitals. The recitals and statements
herein contained are made solely by the Company and the Parent and not by the Trustee, and the Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the validity, adequacy or sufficiency of this
First Supplemental Indenture. All of the provisions contained in the Original Indenture in respect of the rights, privileges, protections, benefits, immunities, powers, and duties of the Trustee shall be applicable in respect of this First
Supplemental Indenture (and any action or inaction hereunder or in connection herewith) as fully and with like force and effect as though set forth in full herein. 

[Signature Pages Follows] 

  
 5 

 IN WITNESS WHEREOF, the parties have caused this First Supplemental Indenture to be duly
executed as of the date first written above. 
  

			
	CANTEL MEDICAL LLC
		
	By:	 	 /s/ Michael J. Tokich

	Name:	 	Michael J. Tokich
	Title:	 	President
	
	STERIS PLC
		
	By:	 	 /s/ Michael J. Tokich

	Name:	 	Michael J. Tokich
	Title:	 	Senior Vice President and Chief Financial Officer
	
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee
		
	By:	 	 /s/ Patrick Giordano 

	Name:	 	Patrick Giordano
	Title:	 	 Vice President

  
 [Signature Page to the
First Supplemental Indenture]EX-10.1

 Exhibit 10.1 

OMNIBUS AMENDMENT TO CANTEL MEDICAL CORP. 2016 EQUITY INCENTIVE PLAN 

AND CANTEL MEDICAL CORP. 2020 EQUITY INCENTIVE PLAN 

STERIS plc, a public limited company incorporated under the laws of Ireland (the “Company”), hereby adopts this Omnibus
Amendment (this “Amendment”) to Cantel Medical Corp. 2016 Equity Incentive Plan (the “2016 Plan”) and Cantel Medical Corp. 2020 Equity Incentive Plan (the “2020 Plan”) (collectively, the
“Plans”) effective as of June 2, 2021. 
 1. In each of the Plans, the definition of “Benefit Plan” in each
Section 2 is hereby amended in its entirety to read as follows: 
 “‘Benefit Plan’ means any employment
agreement, severance agreement or similar agreement between the Participant and the Company (or a Subsidiary) or any long-term incentive plan or similar plan of the Company (or a Subsidiary) which covers the Participant, in each case which includes
provisions relating to an Award granted hereunder.” 
 2. In each of the Plans, the definition of “Board” in each
Section 2 is hereby amended in its entirety to read as follows: 
 “‘Board’ means the Board of Directors of the Company,
and, to the extent of any delegation by the Board of Directors of the Company to the Compensation Committee of the Board of Directors of the Company or any other Committee of the Board of Directors of the Company (or subcommittee thereof) such
Committee (or subcommittee). 
 3. In each of the Plans, the definition of “Change in Control” in each Section 2 is hereby
amended in its entirety to read as follows: 
 “‘Change in Control’ means the consummation of the transactions (the
“Mergers”) contemplated by that certain Agreement and Plan of Merger, dated as of January 12, 2021, entered between the Company, Cantel Medical Corp., Solar New US Holding Co, LLC, and Crystal Merger Sub 1 LLC, as amended (the
“Merger Agreement”). For the avoidance of doubt, no other transactions and/or events that occur following the Closing Date will constitute a Change in Control.” 

4. In each of the Plans, the following definition is added to Section 2 thereof: 

“Closing Date” shall mean the date of consummation of the Mergers. 

5. In each of the Plans, the definition of “Company” in each Section 2 is hereby amended in its entirety to read as follows:

 “‘Company’ means STERIS plc, a public limited company incorporated under the laws of Ireland.” 

6. In each of the Plans, the definition of “Shares” in each Section 2 is hereby amended in its entirety to read as follows:

 “‘Shares’ means ordinary shares of $0.001 each (nominal value) in the capital of the Company.” 

7. All references to “Committee” in each of the Plans, excluding such references contained in the Plans’ definitions of
“Board” as amended by Section 3 hereof, are hereby deleted and replaced with “Board.” 

 8. Section 4 of the Plans shall be amended to add a new subsection (subsection (h) for
the 2020 Pan and subsection (i) for the 2016 Plan) to the end thereof as follows: 
 “Notwithstanding any provision of the Plan to
the contrary, no new Awards shall be granted under the Plan following the Closing Date.” 
 9. Except as specifically modified herein,
the Plans shall remain in full force and effect in accordance with all of the terms and conditions thereof. 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]